Publications by authors named "M Goldfinger"

Claim this Profile
F
Financial Toxicity of Hematologic Malignancy Therapies, Including Cellular Therapy and Its Impact on Access to Care: Prospective Pilot Study.
Lemchukwu Amaeshi, Lauren Laufer, Kateryna Fedorov, Alex Sisto, David Levitz, Mendel Goldfinger

JMIR Cancer· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining drugs that bypass p53 to treat TP53-mutated leukemias.
Sudipta Biswas, Zeinab Albadry M Zahran, Xiaorong Gu, Lisa Cardone, Remuna Marti, Mendel Goldfinger

Blood Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Developing Brains Differ: Pediatric Functional Neurological Disorder: Distinct Clinical Courses, Unique Needs, Personalized Communication, and Pathways to Recovery.
Matthew S Goldfinger, Aaron D Fobian, Itay Tokatly Latzer, Dara V F Albert

Semin Neurol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interventricular Septum Diverticulum: A Multimodality Imaging Approach to Diagnosis.
Romain Van der Linden, Mohamed El Mallouli, Chirine Liu, Maxime Goldfinger, Georgiana Pintea Bentea

Diagnostics (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the performance of the Iceland screens, treats, or prevents multiple myeloma (iStopMM) model in a multicultural Bronx cohort: implications for monoclonal gammopathy of undetermined significance risk stratification.
Rajvi Gor, Jeevan Shivakumar, Pallavi Surana, John Wei, Irina Murakhovskaya, Mendel Goldfinger

Blood Cancer J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis